DCRI NewslettersDCRI newsletters highlight areas in which our faculty and clinical operations experts are engaging in cutting-edge research. Learn how we are helping to advance pragmatic clinical trials, leverage electronic health records, open data to researchers worldwide, drive mobile health and usher in an new era of precision medicine.
The DCRI, Duke University’s MURDOCK Study, and Boehringer Ingelheim Pharmaceuticals Inc. have launched a new collaborative research effort to closely follow people living with chronic obstructive pulmonary disease (COPD).
An analysis by DCRI researchers finds that new statin guidelines would result in 9 million fewer Americans taking the cholesterol-lowering drugs.
The DCRI is teaming up with Verily Life Sciences and Stanford Medicine to conduct a longitudinal study that will collect phenotypic health data from more than 10,000 participants in an effort to create a "baseline" for human health.
An analysis of data three trials assessing the feasibility of using a stem cell therapy to treat patients with the most severe cases of angina, refractory angina, showed a statistically significant improvement in exercise time as well as a reduction in mortality.
Duke Health and DCRI researchers will launch four projects to better understand and treat childhood obesity, including research on the most effective treatments for childhood obesity, basic science research on gut bacteria in overweight children, and more.